Participate in migraines Clinical Trial Today

Active and recruiting trials

  • This clinical trial is closed for recruitment.

    The C-BEOND Study is a Phase 3 study using Dysport® for those with chronic migraines. Approximately 650 participants are expected to take part in North America and Europe.

    For more information, please visit clinicaltrials.gov.

    If you are interested in participating, please contact VEtten@gengepartners.com

  • This clinical trial is closed for recruitment.

    The E-BEOND Study is a Phase 3 study using Dysport® for those with episodic migraines. Approximately 650 participants are expected to take part in North America and Europe.

    For more information, please visit clinicaltrials.gov.

    If you are interested in participating, please contact YBenchaar@gengepartners.com

  • This clinical trial is closed for recruitment.

    A non-interventional study to describe the burden of illness and treatment patterns in patients with migraine.

Active but not recruiting trials

Upcoming trials

  • Real world study with participants treated with UbrogepanT.

    For more information, please contact Vincent VEtten@gengepartners.com

  • More info to come soon!

If you would like to hear about more about our current or upcoming neurological clinical trials in Montreal please contact us at: info@gengepartners.com

“If we’re not in the beginning for rare disease, we may simply be too late for our patients to get the benefit of these new therapies.”

-Angela Genge

  • Scientists or researchers in a laboratory discussing lab results, wearing white lab coats and safety goggles.

    Our mission

    To improve patient health and well-being by conducting cutting-edge clinical research. We strive to foster a culture of innovation, collaboration, and excellence in all aspects of our research, and to contribute to the global effort to improve healthcare for all.

  • Three scientists or medical professionals in lab coats and masks working at a computer in a laboratory.

    Our vision

    To be a leading force in advancing medical knowledge and improving patient care through innovative and ethical clinical research

  • A woman in a lab coat holding a clipboard in a laboratory or greenhouse with glass walls.

    Our future

    Genge Partners will continue to be at the forefront of clinical research, utilizing the latest technologies and methodologies to bring new treatments and therapies to patients in need. Our commitment to patient safety, scientific rigor, and ethical conduct will remain steadfast, as we work to improve healthcare for all and make a lasting impact on the field of medicine.

Our facility:

Genge Partners @ Glen
5100 Boul. de Maisonneuve Ouest, 6th floor
Montreal, QC H4A 3TA

 

© 2022 Genge Partners Inc. All rights reserved | Confidentiality policy